Multiplexed assays reveal effects of missense variants in MSH2 and cancer predisposition

PLoS Genet. 2021 Apr 22;17(4):e1009496. doi: 10.1371/journal.pgen.1009496. eCollection 2021 Apr.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colorectal Neoplasms, Hereditary Nonpolyposis
  • DNA Mismatch Repair / genetics
  • Genetic Predisposition to Disease*
  • Humans
  • MutS Homolog 2 Protein / genetics*
  • Mutation, Missense / genetics
  • Neoplasms / genetics*
  • Neoplasms / pathology

Substances

  • MSH2 protein, human
  • MutS Homolog 2 Protein

Grants and funding

Our research is supported by the PRISM (Protein Interactions and Stability in Medicine and Genomics) centre funded by the Novo Nordisk Foundation (to RHP, AS and KLL; NNF18OC0033950) and the Lundbeck Foundation (to AS; R272-2017-4528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.